Decoy Therapeutics (DCOY) Non-Current Deffered Revenue (2014 - 2018)
Decoy Therapeutics (DCOY) posted quarterly Non-Current Deffered Revenue of $9804.0 for Q2 2018, down 89.33% year-over-year from $91878.0 in Q2 2017, and down 60.0% quarter-over-quarter from $24509.0 in Q1 2018.
Decoy Therapeutics (DCOY) Non-Current Deffered Revenue (2014 - 2018) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Non-Current Deffered Revenue for 5 consecutive years, with $9804.0 the latest figure, recorded in Q2 2018.
- In Q2 2018, Non-Current Deffered Revenue fell 89.33% year-over-year to $9804.0; the TTM figure through Jun 2018 stood at $9804.0 (down 89.33% YoY), while the FY2017 annual figure was $39214.0, up 366.94% from the prior year.
- Non-Current Deffered Revenue fell to $9804.0 in Q2 2018 per DCOY's latest filing, from $24509.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $91878.0 in Q2 2017 and bottomed at $8398.0 in Q4 2016.
- Historically, Non-Current Deffered Revenue has averaged $31084.1 across 5 years, with a median of $24509.0 in 2018.
- Annual changes were most pronounced in 2017 — Non-Current Deffered Revenue soared 486.85% — and 2018, when it tumbled 89.33%.
- Decoy Therapeutics' Non-Current Deffered Revenue stood at $35968.0 in 2014, then tumbled by 59.44% to $14587.0 in 2015, then slumped by 42.43% to $8398.0 in 2016, then jumped by 366.94% to $39214.0 in 2017, then plunged by 75.0% to $9804.0 in 2018.
- Business Quant data shows DCOY's Non-Current Deffered Revenue at $9804.0 in Q2 2018, $24509.0 in Q1 2018, and $39214.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 220.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 147.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 9,804.00 |
| Mar 31, 2018 | 24,509.00 |
| Dec 31, 2017 | 39,214.00 |
| Sep 30, 2017 | 53,919.00 |
| Jun 30, 2017 | 91,878.00 |
| Mar 31, 2017 | 59,111.00 |
| Dec 31, 2016 | 8,398.00 |
| Sep 30, 2016 | 10,561.00 |
| Jun 30, 2016 | 15,656.00 |
| Mar 31, 2016 | 22,575.00 |
| Dec 31, 2015 | 14,587.00 |
| Sep 30, 2015 | 22,807.00 |
| Jun 30, 2015 | 27,527.00 |
| Mar 31, 2015 | 29,748.00 |
| Dec 31, 2014 | 35,968.00 |